Saturday, September 13, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Micron Stock Hits Record High Ahead of Earnings: Can It Justify the Rally?

Dieter Jaworski by Dieter Jaworski
September 13, 2025
in Analysis, Earnings, Nasdaq, Semiconductors, Trading & Momentum
0
Micron Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Shares of memory chip manufacturer Micron Technology surged dramatically this week, propelled by a significant analyst upgrade. The stock reached an unprecedented peak just days before its highly anticipated quarterly report, scheduled for September 23rd. This impressive run-up leaves investors questioning whether the company can meet these elevated expectations or if a pullback is imminent.

The AI Boom Fuels Unprecedented Demand

The core of the optimism surrounding Micron lies in its strategic positioning within the booming artificial intelligence infrastructure sector. The company’s revenue from high-bandwidth memory (HBM) products soared by nearly 50% in its fiscal third quarter of 2025. This segment is now on an annual run rate of approximately $6 billion.

A crucial market shift is driving this demand. As AI development progresses from pure training to inference applications, the need for dynamic random-access memory (DRAM) and NAND flash products is accelerating rapidly. Some market experts, including those at Citigroup, are forecasting a potential supply shortage for these critical memory components by 2026.

Citigroup Raises Price Target to $175

The immediate catalyst for the recent share price appreciation was a major upgrade from Citigroup. On Thursday, analyst Christopher Danely lifted his price target from $150 to $175, triggering a substantial single-day gain of roughly 8%.

Should investors sell immediately? Or is it worth buying Micron?

Danely’s rationale centers on a memory market recovery that is being fueled by constrained production capacity and stronger-than-anticipated demand, particularly from the data center industry. While he anticipates quarterly results that are largely in line with expectations, he predicts management will provide forward guidance “significantly above consensus.” This outlook is based on projections for increased sales volumes and rising prices for both DRAM and NAND products. This positive sentiment has contributed to the stock’s impressive year-to-date advance of almost 80%.

All Eyes on the September 23rd Earnings Report

The upcoming quarterly figures, due on September 23rd, will serve as the ultimate test for the recent rally. Wall Street analysts are projecting adjusted earnings per share of around $2.85, which represents a dramatic improvement over the $1.18 reported in the year-ago period. Revenue is expected to hit $11.1 billion, equating to a 43% year-over-year increase.

However, the management’s forward-looking commentary will be even more critical than the historical numbers. Investors will be listening intently for confirmation of the robust demand trends and updates on the progress of the high-margin HBM business, where Micron is already shipping samples of its next-generation HBM4 product to customers.

Valuation Remains Compelling Despite the Surge

Even after this powerful rally, Micron’s valuation does not appear stretched. With a forward price-to-earnings ratio sitting below 11 for the coming year, the current share price does not yet fully reflect the projected earnings growth of 58%. The central question for the market remains whether Micron can deliver on these high expectations and continue to convince investors of its compelling AI-driven growth narrative.

Ad

Micron Stock: Buy or Sell?! New Micron Analysis from September 13 delivers the answer:

The latest Micron figures speak for themselves: Urgent action needed for Micron investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 13.

Micron: Buy or sell? Read more here...

Tags: Micron
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Viking Therapeutics Stock
Analysis

Viking Therapeutics Faces Investor Scrutiny Over Weight-Loss Drug Tolerability

September 13, 2025
Orange County Stock
Analysis

Orange County Bancorp: A Tale of Steady Dividends and Mounting Credit Concerns

September 13, 2025
Acacia Research Stock
Analysis

Acacia Research Shares Plummet Despite Record Revenue Growth

September 13, 2025
Next Post
CubeSmart Stock

CubeSmart Shares Face Pressure Following Unexpected Downgrade

Lumentum Stock

Strategic Financing Ignites Lumentum Stock Rally

NASDAQ 100 Stock

Tech Stocks Propel Nasdaq 100 to Unprecedented Heights

Recommended

Five Bancorp Stock

Regional Banks Face Fed Policy Crossroads as Five Bancorp Shares Fluctuate

1 week ago
Cheniere Energy Stock

America’s Quiet Energy Giant Powers Global Transition

3 weeks ago
Dow Inc Stock

Dow Secures Major $540 Million Infrastructure Investment Amid Market Challenges

2 weeks ago
AMT stock news

Strategic Acquisition: SG Americas Securities LLC Invests in RxSight, Inc. to Drive Medical Technology Advancements

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alphabet Amazon AMD AMZN Apple BA BigBear.ai BioNTech Broadcom Coinbase DIS Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF MSFT NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir Pepsi Realty Income Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla Tilray TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Institutional Investors Flock to Northeast Bancorp on Strong Quarterly Performance

Landmark Ruling Secures Alphabet’s Core Business Model

MP Materials Shares Face Selling Pressure Despite Robust Financial Results

Aviat Networks Stock Surges on Stellar Earnings and Analyst Upgrade

Turtle Beach Forges PlayStation Alliance with New Gaming Headset

Is Blue Foundry Bancorp a Hidden Gem or a Value Trap?

Trending

Viking Therapeutics Stock
Analysis

Viking Therapeutics Faces Investor Scrutiny Over Weight-Loss Drug Tolerability

by Robert Sasse
September 13, 2025
0

Investors are reassessing Viking Therapeutics' clinical trial data as concerns emerge about patient discontinuation rates in the...

Orange County Stock

Orange County Bancorp: A Tale of Steady Dividends and Mounting Credit Concerns

September 13, 2025
Acacia Research Stock

Acacia Research Shares Plummet Despite Record Revenue Growth

September 13, 2025
Northeast Bancorp Stock

Institutional Investors Flock to Northeast Bancorp on Strong Quarterly Performance

September 13, 2025
Alphabet Stock

Landmark Ruling Secures Alphabet’s Core Business Model

September 13, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Viking Therapeutics Faces Investor Scrutiny Over Weight-Loss Drug Tolerability September 13, 2025
  • Orange County Bancorp: A Tale of Steady Dividends and Mounting Credit Concerns September 13, 2025
  • Acacia Research Shares Plummet Despite Record Revenue Growth September 13, 2025

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com